Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 47

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 47
---
 |     | $ |  99.88 |     | $          |  -74,286 |     | $               | 358,653 |
| 2021                        |     | $                                                                           | 5,071,358 |     | $                                    |  13,341,251 |     | $                                                         | 2,648,345 |     | $                                                     | 3,791,063 |     | $                                                | 126.84 |     | $ | 152.33 |     | $          |  103,135 |     | $               | 260,699 |
| 2020                        |     | $                                                                           | 3,312,999 |     | $                                    |  14,340,707 |     | $                                                         | 1,556,685 |     | $                                                     | 2,226,976 |     | $                                                | 114.63 |     | $ | 126.91 |     | $          |   86,870 |     | $               | 243,023 |

_________________________________

(1) Amounts reported in this column represent (i) the total compensation reported in the Summary Compensation Table for the applicable year for the Company's PEO, Vivek Jainand (ii) the average of the total compensation reported in the Summary Compensation Table for the applicable year for the Company’s non-PEO named executive officers (NEOs).

(2) The Company's non-PEO NEOs for the applicable years 2024, 2023, 2022 and 2021 were Brian Bonnell, Christian Voigtlander, Daniel Woolson and Virginia Sanzone. The Company's non-PEO NEOs for 2020 were Brian Bonnell, Christian Voigtlander, Scott Lamb, Daniel Woolson and Virginia Sanzone.

(3) Amounts reported in the applicable column represent (i) the compensation actually paid to the PEO and (ii) the average compensation actually paid to the non-PEO NEOs. The fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value at grant in accordance with ASC Topic 718. For time-based RSUs the valuation assumptions used to determine the change in the fair market value of the respective PEO and non-PEO NEO equity awards for each respective year use the stock price as of year-end or as of the applicable exercise/vesting date. For PRSUs,